NeuPath Health Financials
NPTH Stock | CAD 0.17 0.01 6.25% |
Operating Margin 0.0391 | Profit Margin (0) | Return On Equity 0.0003 |
NeuPath | Select Account or Indicator |
Please note, the imprecision that can be found in NeuPath Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of NeuPath Health. Check NeuPath Health's Beneish M Score to see the likelihood of NeuPath Health's management manipulating its earnings.
NeuPath Health Stock Summary
NeuPath Health competes with East Side, Metalero Mining, Globex Mining, Ramp Metals, and Arbor Metals. NeuPath Health Inc. provides chronic pain management services in Canada. The company operates 13 clinics under the Centres for Pain Management and InMedic Creative Medicine brands in Ontario and Alberta. NEUPATH HEALTH operates under Medical Care Facilities classification in Exotistan and is traded on Commodity Exchange.Foreign Associate | USA |
Specialization | Health Care, Health Care Equipment & Services |
Instrument | Canada Stock View All |
Exchange | TSX Venture Exchange |
ISIN | CA64133P1009 |
Business Address | 6400 Millcreek Drive, |
Sector | Health Care Providers & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.neupath.com |
Phone | 905 858 1368 |
Currency | CAD - Canadian Dollar |
You should never invest in NeuPath Health without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of NeuPath Stock, because this is throwing your money away. Analyzing the key information contained in NeuPath Health's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
NeuPath Health Key Financial Ratios
There are many critical financial ratios that NeuPath Health's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that NeuPath Health reports annually and quarterly.Revenue | 66.1 M | ||||
Gross Profit | 10.82 M | ||||
EBITDA | 2.07 M | ||||
Net Income | (107 K) | ||||
Total Asset | 41.78 M |
NeuPath Health Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Other Current Liab | 1.7M | 1.9M | 611K | 432K | 388.8K | 369.4K | |
Other Liab | 96K | 59K | 215K | 33K | 29.7K | 28.2K | |
Net Tangible Assets | (10.9M) | 7.8M | 2.1M | 63K | 72.5K | 76.1K | |
Retained Earnings | (13.5M) | (18.5M) | (21.8M) | (25.9M) | (26.0M) | (27.3M) | |
Accounts Payable | 5.2M | 5.6M | 7.5M | 8.8M | 7.5M | 6.5M | |
Net Receivables | 7.2M | 5.9M | 6.6M | 7.0M | 6.7M | 6.5M | |
Other Current Assets | 614K | 634K | 988K | 670K | 606K | 592.6K | |
Total Current Assets | 8.6M | 19.3M | 15.4M | 11.1M | 10.7M | 12.4M | |
Common Stock | 11.5M | 32.8M | 36.8M | 39.9M | 45.9M | 24.6M |
NeuPath Health Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 1.9M | 1.5M | 876K | 832K | 928K | 949.3K | |
Ebit | (661K) | (820K) | (1.8M) | (1.3M) | (1.4M) | (1.5M) | |
Income Tax Expense | (85K) | 198K | (17K) | 194K | 223.1K | 234.3K |
NeuPath Health Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (539K) | 10.0M | (4.9M) | (4.4M) | 1.7M | 1.7M | |
Net Borrowings | (2.1M) | (2.8M) | (3.6M) | (3.7M) | (3.3M) | (3.2M) | |
Depreciation | 2.5M | 2.5M | 3.1M | 2.7M | 2.6M | 2.4M | |
Capital Expenditures | 131K | 38K | 411K | 1.2M | 353K | 452.0K | |
Net Income | (5.3M) | (5.1M) | (3.2M) | (4.2M) | (107K) | (112.4K) | |
Change To Netincome | 3.3M | 3.1M | 889K | 2.0M | 2.3M | 2.3M | |
End Period Cash Flow | 883K | 10.9M | 5.9M | 1.5M | 3.2M | 4.4M |
NeuPath Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NeuPath Health's current stock value. Our valuation model uses many indicators to compare NeuPath Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NeuPath Health competition to find correlations between indicators driving NeuPath Health's intrinsic value. More Info.NeuPath Health is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 48.67 of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NeuPath Health's earnings, one of the primary drivers of an investment's value.NeuPath Health Systematic Risk
NeuPath Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. NeuPath Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on NeuPath Health correlated with the market. If Beta is less than 0 NeuPath Health generally moves in the opposite direction as compared to the market. If NeuPath Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one NeuPath Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of NeuPath Health is generally in the same direction as the market. If Beta > 1 NeuPath Health moves generally in the same direction as, but more than the movement of the benchmark.
NeuPath Health Other Current Liab Over Time
NeuPath Health Thematic Clasifications
NeuPath Health is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas
Health Management | View |
NeuPath Health December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of NeuPath Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NeuPath Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of NeuPath Health based on widely used predictive technical indicators. In general, we focus on analyzing NeuPath Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NeuPath Health's daily price indicators and compare them against related drivers.
Downside Deviation | 5.95 | |||
Information Ratio | (0.02) | |||
Maximum Drawdown | 12.13 | |||
Value At Risk | (5.88) | |||
Potential Upside | 6.25 |
Additional Tools for NeuPath Stock Analysis
When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.